| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 27, 2026
Newly published insights from the ALLEVIATE-HF clinical trial found a high rate of actionable arrhythmias in heart failure patients, leading to therapeutic intervention
-
May 20, 2026
EuroPCR Hot Line Science features positive outcomes from the largest international head-to-head comparative trial of TAVR
-
May 14, 2026
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill
-
May 5, 2026
New VitalFlow Transport Frame AG advances care for transport for ECMO patients between medical facilities
-
Apr 29, 2026
Company recognized as one of the 10 most influential in health and life sciences category
-
Apr 29, 2026
First procedure performed at Axia Women’s Health by Dr. Vincent R. Lucente
-
Apr 29, 2026
Next generation mitral valve, designed to facilitate patient lifetime management and setting new benchmark for ease of use in small incision surgery1-3 reports first uses in sternotomy, Minimally Invasive Cardiac Surgery (MICS) and robotic cases
-
Apr 29, 2026
Recognition highlights Medtronic as a leading workplace for career growth across key European markets
-
Apr 25, 2026
Heart Rhythm 2026: Real-world outcomes reinforce Aurora EV-ICD system as a reliable option for indicated patients requiring protection from dangerously fast heart rhythms
-
Apr 15, 2026
Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population1
-
Mar 29, 2026
Multicenter ALERT Trial demonstrates potential to advance treatment pathway to minimally invasive heart valve therapies for underserved patient populations
-
Mar 28, 2026
EMBRACE trial to study renal denervation with the Symplicity Spyral™ system and percutaneous coronary intervention (PCI) in the same procedure In SPYRAL HTN ON and OFF MED trials, patients...
-
Feb 19, 2026
Milestone expands patient access to the first and most studied renal denervation therapy for hypertension.
-
Feb 17, 2026
Infuse™ is the only PMA-approved growth factor bone graft indicated for ALIF, OLIF, and TLIF
-
Feb 5, 2026
Medtronic in India drives awareness on Bradycardia with #DecodeYourRhythm Campaign.





